2025. CD8+ as a Predictive Factor for Response to Anthracycline-Based Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer at Dr. Soetomo General Hospital, Surabaya, January 2024-August 2025. Vascular and Endovascular Review. 8, 13s (Nov. 2025), 155–161. DOI:https://doi.org/10.64149/.